Independent Business
UK · 9 mins ago
AstraZeneca share prices drop amid £300bn mega-merger talks with US rival
The merger would mark one of the industry’s largest ever deals and create the world’s fourth largest pharmaceutical company
Do you trust Independent Business?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!